-
1
-
-
0002394897
-
The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents
-
White HS, Brown D, Skeen GA, Wolf HH, Twyman RE. The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents. Epilepsia 1995:36(Suppl 3):S39.
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 3
-
-
White, H.S.1
Brown, D.2
Skeen, G.A.3
Wolf, H.H.4
Twyman, R.E.5
-
2
-
-
0002394897
-
The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neurons
-
White HS, Brown D, Skeen GA, Twyman RE. The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neurons. Epilepsia 1995;36(Suppl 4):S34.
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 4
-
-
White, H.S.1
Brown, D.2
Skeen, G.A.3
Twyman, R.E.4
-
3
-
-
0002836371
-
Topiramate selectively blocks kainate currents in cultured hippocampal neurons
-
Severt L, Coulter DA, Sombati S, DeLorenzo RJ. Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia 1995;36(Suppl 4):S38.
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 4
-
-
Severt, L.1
Coulter, D.A.2
Sombati, S.3
DeLorenzo, R.J.4
-
4
-
-
0030998625
-
Preliminary observations on topiramate in pediatric epilepsies
-
Glauser TA. Preliminary observations on topiramate in pediatric epilepsies. Epilepsia 1997;38(Suppl 1):S37-S41.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Glauser, T.A.1
-
5
-
-
0031823461
-
Topiramate use in pediatric patients
-
Glauser TA. Topiramate use in pediatric patients. Can J Neurol Sci 1998;25:S8-S12.
-
(1998)
Can J Neurol Sci
, vol.25
-
-
Glauser, T.A.1
-
6
-
-
0030893439
-
Pharmacokinetic and interaction profile of topiramate: Review and comparison with other newer antiepileptic drugs
-
Johannessen SI. Pharmacokinetic and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 1997;38(Suppl 1):SI8-S23.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Johannessen, S.I.1
-
7
-
-
0030998125
-
Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience
-
Faught E. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience. Epilepsia 1997;38(Suppl 1):S24-S27.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Faught, E.1
-
8
-
-
0030997223
-
Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience
-
Ben-Menachem E. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience. Epilepsia 1997;38(Suppl 1):S28-S30.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Ben-Menachem, E.1
-
9
-
-
0030896790
-
Long-term experience with topiramate as adjunctive therapy and as mono-therapy in patients with partial onset seizures: Retrospective survey of open-label treatment
-
Rosenfeld WE, Sachdeo RC, Faught RE, Privitera M. Long-term experience with topiramate as adjunctive therapy and as mono-therapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 1997;38(Suppl 1):S34-S36.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Rosenfeld, W.E.1
Sachdeo, R.C.2
Faught, R.E.3
Privitera, M.4
-
10
-
-
0031000085
-
Preliminary open-label experience with topiramate in primary generalized seizures
-
Biton V. Preliminary open-label experience with topiramate in primary generalized seizures. Epilepsia 1997;38(Suppl 1):S42-S44.
-
(1997)
Epilepsia
, vol.38
, Issue.SUPPL. 1
-
-
Biton, V.1
-
11
-
-
0029822510
-
New antiepileptic drugs: A systematic review of their efficacy and tolerability
-
Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. Br Med J 1996;313:1169-1174.
-
(1996)
Br Med J
, vol.313
, pp. 1169-1174
-
-
Marson, A.G.1
Kadir, Z.A.2
Chadwick, D.W.3
-
12
-
-
0031820935
-
Topiramate - Safety and tolerability
-
Jones MW. Topiramate - safety and tolerability. Can J Neurol Sci 1998;25:S13-S15
-
(1998)
Can J Neurol Sci
, vol.25
-
-
Jones, M.W.1
|